Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Variance in guideline compliance attributed to surgeon preference
October 27th, 2005
Variance in guideline compliance could be attributed to surgeon preference. "This population-based study aimed to analyze variations in surgical treatment and guideline compliance with respect to the application of radiotherapy and axillary lymph node dissection (ALND), for early breast cancer, before and after the sentinel node biopsy (SNB) introduction. The study included 13,532 consecutive surgically treated stage I-IIIA breast cancer patients diagnosed in 1989-2002," researchers in the Netherlands reported. "Hospitals showed large variation in breast-conserving surgery (BCS) rates, ranging between 27 and 72% for T1 and 14 and 42% for T2 tumors....
Source: Women's Health Weekly (2005-10-27)
|
